Use of the SPARC microenvironment signature in the treatment of cancer
US9193782B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2011 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | May 20, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides multiparametric anti-SPARC antibody-based techniques for predicting the response to chemotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.